Cargando…
Palmitic acid‐ and cysteine‐functionalized nanoparticles overcome mucus and epithelial barrier for oral delivery of drug
Nanoparticles (NPs) used for oral administration have greatly improved drug bioavailability and therapeutic efficacy. Nevertheless, NPs are limited by biological barriers, such as gastrointestinal degradation, mucus barrier, and epithelial barrier. To solve these problems, we developed the PA‐N‐2‐HA...
Autores principales: | Xie, Yinzhuo, Jin, Zheng, Ma, Da, Yin, Tan Hui, Zhao, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189451/ https://www.ncbi.nlm.nih.gov/pubmed/37206211 http://dx.doi.org/10.1002/btm2.10510 |
Ejemplares similares
-
Chondroitin sulfate functionalized palmitic acid and cysteine cografted-quaternized chitosan for CD44 and gut microbiota dual-targeted delivery of curcumin
por: Xie, Yinzhuo, et al.
Publicado: (2023) -
Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicalein
por: Dong, Wujun, et al.
Publicado: (2020) -
The Mucoadhesive Nanoparticle-Based Delivery System in the Development of Mucosal Vaccines
por: Zhao, Kai, et al.
Publicado: (2022) -
Peptide Antibiotic–Polyphosphate
Nanoparticles:
A Promising Strategy to Overcome the Enzymatic and Mucus Barrier of
the Intestine
por: Saleh, Ahmad, et al.
Publicado: (2023) -
Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
por: Thomas, Oliver S., et al.
Publicado: (2019)